Cargando…
The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges
BACKGROUND: Hepatitis C infection (HCV) can have a harmful effect on the health of people and can impose relevant healthcare costs. The World Health Organization has identified the elimination of Hepatitis C by 2030 as an important goal for all countries. This study aimed to identify the HCV-related...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore Srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225642/ https://www.ncbi.nlm.nih.gov/pubmed/32490276 http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.1.1438 |
_version_ | 1783534112779272192 |
---|---|
author | BEHZADIFAR, M. AZARI, S. GORJI, H.A. MARTINI, M. BRAGAZZI, N.L. |
author_facet | BEHZADIFAR, M. AZARI, S. GORJI, H.A. MARTINI, M. BRAGAZZI, N.L. |
author_sort | BEHZADIFAR, M. |
collection | PubMed |
description | BACKGROUND: Hepatitis C infection (HCV) can have a harmful effect on the health of people and can impose relevant healthcare costs. The World Health Organization has identified the elimination of Hepatitis C by 2030 as an important goal for all countries. This study aimed to identify the HCV-related policies in Iran. METHODS: A qualitative approach was used for this study. Data was collected through a comprehensive search of documents and interviews with different stakeholders related to the HCV program. Data was analyzed and validated using content analysis based on the policy triangle framework. RESULTS: Our findings highlighted that certain social and cultural issues related to stigma can impact on awareness-raising processes. It is also necessary to consider HCV directly in the context of government policies. All relevant stakeholders should be included. Continued talks and interactions need to be made between them for the active participation of all actors. CONCLUSION: The findings of this study can provide useful information for improving, supporting and developing policy processes. Healthcare providers should address all aspects of the disease by 2030 in order to achieve the goal of HCV elimination. Evidence-based planning, support for up-to-date policies and resource mobilization are needed to achieve this ambitious goal. |
format | Online Article Text |
id | pubmed-7225642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Pacini Editore Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-72256422020-06-01 The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges BEHZADIFAR, M. AZARI, S. GORJI, H.A. MARTINI, M. BRAGAZZI, N.L. J Prev Med Hyg Review BACKGROUND: Hepatitis C infection (HCV) can have a harmful effect on the health of people and can impose relevant healthcare costs. The World Health Organization has identified the elimination of Hepatitis C by 2030 as an important goal for all countries. This study aimed to identify the HCV-related policies in Iran. METHODS: A qualitative approach was used for this study. Data was collected through a comprehensive search of documents and interviews with different stakeholders related to the HCV program. Data was analyzed and validated using content analysis based on the policy triangle framework. RESULTS: Our findings highlighted that certain social and cultural issues related to stigma can impact on awareness-raising processes. It is also necessary to consider HCV directly in the context of government policies. All relevant stakeholders should be included. Continued talks and interactions need to be made between them for the active participation of all actors. CONCLUSION: The findings of this study can provide useful information for improving, supporting and developing policy processes. Healthcare providers should address all aspects of the disease by 2030 in order to achieve the goal of HCV elimination. Evidence-based planning, support for up-to-date policies and resource mobilization are needed to achieve this ambitious goal. Pacini Editore Srl 2020-04-02 /pmc/articles/PMC7225642/ /pubmed/32490276 http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.1.1438 Text en ©2020 Pacini Editore SRL, Pisa, Italy https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-Non-Commercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en |
spellingShingle | Review BEHZADIFAR, M. AZARI, S. GORJI, H.A. MARTINI, M. BRAGAZZI, N.L. The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges |
title | The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges |
title_full | The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges |
title_fullStr | The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges |
title_full_unstemmed | The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges |
title_short | The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges |
title_sort | hepatitis c virus in iran: health policy, historical, ethical issues and future challenges |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225642/ https://www.ncbi.nlm.nih.gov/pubmed/32490276 http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.1.1438 |
work_keys_str_mv | AT behzadifarm thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT azaris thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT gorjiha thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT martinim thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT bragazzinl thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT behzadifarm hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT azaris hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT gorjiha hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT martinim hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges AT bragazzinl hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges |